More effective and less resistance-prone antiviral agents are now available to treat hepatitis
B virus (HBV) infection. Profound, durable, therapeutic HBV DNA suppression to slow and …

Large amounts of new data on the natural history and treatment of chronic hepatitis B virus
(HBV) infection have become available since 2005. These include long-term follow-up …

Our understanding of the natural history of hepatitis B virus (HBV) infection and the potential
for therapy of the resultant disease is continuously improving. New data have become …

These guidelines have been written to assist physicians and other health care providers in
the recognition, diagnosis, and management of patients chronically infected with the …

Background The effectiveness of antiviral therapy in preventing disease progression in
patients with chronic hepatitis B and advanced fibrosis or cirrhosis is unknown. Methods …

These are the first World Health Organization (WHO) guidelines for the prevention care and
treatment of persons living with CHB infection and complement similar recent published …

Background Entecavir is a potent and selective guanosine analogue with significant activity
against hepatitis B virus (HBV). Methods In this phase 3, double-blind trial, we randomly …

Summary Background Treatment of HBeAg-positive patients with chronic hepatitis B is not
effective in most. A combination of immunomodulatory pegylated interferon alfa-2b and …

Background & aims: Data on thelong-term safety of lamivudine are limited. The aim of this
analysis was to determine the incidence of hepatitis flares, hepatic decompensation, and …

These guidelines have been written to assist physicians and other health care providers in
the recognition, diagnosis, and management of patients chronically infected with the …